Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1299
https://www.valueinhealthjournal.com/article/S1098-3015(15)03375-6/fulltext
Title :
Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03375-6&doi=10.1016/j.jval.2015.09.1299
First page :
A479
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
791